Skip to main content
. Author manuscript; available in PMC: 2015 Apr 7.
Published in final edited form as: Expert Opin Drug Deliv. 2014 Mar 20;11(5):711–721. doi: 10.1517/17425247.2014.897693

Table 1.

Summary of the advantages and disadvantages of current methods used to circumvent the BBB for drug delivery to the brain

Strategy Advantages Disadvantages
Intracranial injection
  • Delivery to targeted brain regions

  • Achieve therapeutic dose

  • Invasive

  • Damage to healthy tissue

Drug Modification
  • Option for personalized medicine

  • Noninvasive

  • Difficult to achieve therapeutic concentration in vivo

  • Expensive and difficult to develop

  • Non-targeted

Intranasal Delivery
  • Successful in pre-clinical studies

  • Drugs must travel great distance in the brain

  • Difficult to achieve therapeutic concentrations in vivo

Global BBB disruption
  • Transient opening

  • Can achieve therapeutic concentrations

  • Non-targeted – entire BBB is disrupted

Focused Ultrasound
  • Targeted to sub millimeter regions in the brain

  • Non-invasive

  • Therapeutic concentrations

  • Only relatively short term studies have been performed.

HHS Vulnerability Disclosure